Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs Teucrium Soybean Fund (SOYB) Price & Performance

Becton Dickinson and CoTrade
Teucrium Soybean FundTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Teucrium Soybean Fund — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Teucrium Soybean Fund trades at $24.92. The key difference: Becton Dickinson and Co pays a 2.34% dividend while Teucrium Soybean Fund pays none, and Becton Dickinson and Co is trading nearer its 52-week high, Teucrium Soybean Fund nearer its low. Which is the better fit depends on your goals.

BDXSOYB
Market Cap
$48.93B
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$185.39$26.28
52-Week Low
$138.62$21.46
Enterprise Value
$65.03B
Dividend Yield
2.34%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.

The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.

Teucrium Soybean Fund

SOYB trades at $25.04, showing minimal daily change of 0.03%. Technical indicators suggest a bearish bias with moving averages signaling caution, though oscillators are neutral. Recent news highlights potential agricultural sector tailwinds from China's $17 billion crop purchase pledge through 2028, which could benefit U.S. exporters like SOYB. However, key financial ratios including P/E, P/S, and profitability metrics are currently unavailable, limiting fundamental clarity.

The stock faces near-term technical headwinds but may find support from positive agricultural trade developments. Investment opportunity hinges on improved financial disclosure and sector momentum, while risks include geopolitical tensions and lack of transparent fundamentals. Investors require updated earnings reports to assess valuation properly.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About Teucrium Soybean Fund

SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.

Read more on SOYB